Efficacy and safety analysis of icotinib hydrochloride combined with anlotinib in the first-line treatment of advanced non-small cell lung cancer

Cao Ranhua; Hu Qun

doi:10.3760/j.issn.1673-4777.2023.11.008

Home>Articles>Efficacy and safety analysis of icotinib hydrochloride combined with anlotinib in the first-line treatment of advanced non-small cell lung cancer

DOI: 10.3760/j.issn.1673-4777.2023.11.008

Efficacy and safety analysis of icotinib hydrochloride combined with anlotinib in the first-line treatment of advanced non-small cell lung cancer

Cao Ranhua

Hu Qun

Keywords：Non-small cell lung cancerIcotinib hydrochlorideAnlotinib

Publication Date：2023-11-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1632-1636 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2023,18(11)